Latest News for: molecular

Edit

Sapphiros Secures $12.4 Million BARDA Award to Advance Rapid Molecular Diagnostics for Biothreat Detection

Image The Pilot News 15 Jul 2026
Multi-year program supports development of disposable molecular diagnostic platforms for point-of-care, field-use, and emergency response settings ... .
Edit

Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference (Molecular Partners AG)

Public Technologies 15 Jul 2026
ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., July 15, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX ... Molecular Partners expects to announce a third Radio-DARPin program, targeting a different tumor target, in 2026.
Edit

[Latest] Point-Of-Care Molecular Diagnostics Market to Grow Rapidly, Hitting US$ 17.94 Bn by 2034 at ...

Nasdaq Globe Newswire 14 Jul 2026
Point-of-care molecular diagnostics market size is projected to reach USD 17.94 Bn by 2034 from its value of USD 8.46 billion in 2024, at a CAGR of 8.70% ... .
Edit

Sapphiros Secures $12.4 Million BARDA Award to Advance Rapid Molecular Diagnostics for Biothreat Detection (Sapphiros LLC)

Public Technologies 14 Jul 2026
Multi-year program supports development of disposable molecular diagnostic platforms for point-of-care, field-use, and emergency response settings ... To ensure biosafety, the Sapphiros molecular device ...
Edit

Statement of Changes in Beneficial Ownership (Form 4) (4D Molecular Therapeutics Inc)

Public Technologies 14 Jul 2026
) FORM 4. Check this box if no longer subject to Section 16 ... See Instruction 1(b) ... OMB Number ... 2 ... 4D Molecular Therapeutics, Inc ... C/O 4D MOLECULAR THERAPEUTICS INC., 5858 HORTON STREET #455 3 ... C/O 4D MOLECULAR THERAPEUTICS INC ... 4D Molecular Therapeutics Inc.
Edit

Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular ...

Nasdaq Globe Newswire 13 Jul 2026
At RDE of 32 mg QD, encouraging monotherapy responses with 57% uORR in 2L+ KRAS G12X pancreatic cancer in U.S. trial and median relative dose intensity of 100% ... .
Edit

From killer to rescuer: the molecular revolution and AI era in TB prevention

Madhyamam 13 Jul 2026
Tuberculosis (TB), once considered a virtual “death sentence,” is now entering a new era of hope thanks to advances in molecular medicine and AI-driven healthcare technologies ... to molecular diagnosis.
Edit

Erasca Announces Updated Preliminary Phase 1 Data and Registration-Enabling Plans for Potentially Best-in-Class Pan-RAS Molecular Glue ERAS-0015 in KRAS-Mutant Solid Tumors (Erasca Inc)

Public Technologies 13 Jul 2026
ERAS-0015 is an investigational, oral, highly potent pan-RAS molecular glue designed to inhibit RAS signaling with a potential best-in-class profile.
Edit

Self‑building molecular rings bring next‑generation drug delivery and smart materials closer

Phys Dot Org 12 Jul 2026
It gives them the stability and tunable properties needed for applications ranging from targeted drug delivery and biosensing to designing precise molecular machines ... A broader route to molecular machines.
Edit

Low-cost genome sequencing approach is powering genetics research on mental illness and many other studies

Phys Dot Org 12 Jul 2026
For researchers on the hunt for the genetic roots of disease, the cost of deep whole-genome sequencing makes it challenging to conduct large genetic studies involving thousands of participants, which are needed to reveal new genetic insights ... Toni A.
Edit

Intricate molecular mechanisms help bacteria evade immune detection

Phys Dot Org 11 Jul 2026
Until now, however, the molecular mechanisms driving pilin antigenic variation have remained elusive, according to Seifert ... Host-Pathogen InteractionsImmune EvasionEvolution, Molecular.
×